Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-articular infliximab in knee mono-arthritis
2006-001448-29Phase 4Completed
- Sponsor
- St George's University Hospitals NHS Foundation Trust
- Start
- Sep 2006
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of infliximab in autoimmune arthritis, seronegative rheumatoid arthritis (SNRA), psoriatic arthritis (PsA) and 3 more, sponsored by St George's University Hospitals NHS Foundation Trust. Primary endpoint: Ultrasound power Doppler response. Started Sep 2006; status: completed.
02
Drugs
infliximab
03
Conditions
autoimmune arthritisseronegative rheumatoid arthritis (SNRA)psoriatic arthritis (PsA)enteropathic arthritis (EA)reactive arthritis
Beyond the preview
Go deeper on 2006-001448-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001448-29.